Economic Evaluation of Positron Emission Tomography (PET) in Non Small Cell Lung Cancer (NSCLC), CHERE Working Paper 2007/6



Variable

Input/ Assumption

Base Case Patient

62 year old man, NSCLC confirmed and fit
for surgery or non surgical treatment.
___________________
(Dietlein)___________________

Diagnostic accuracy

Sensitivity of FDG PET if CT
negative

86% with 95% CI (0.79, 0.91) - (HTBS)

Specificity of FDG PET if CT
negative

90% with 95% CI (0.87, 0.93) - (HTBS)

Sensitivity of FDG PET if CT
positive

92% with 95% CI (0.87, 0.95) - (HTBS)

Specificity of FDG PET if CT
_______________
positive_______________

76% with 95% CI (0.69, 0.82) - (HTBS)

Sensitivity of FDG PET detecting

__________distant Metastasis__________

93% - (NICE)

Sensitivity of Mediastinoscopy

72% - (Dietlein)

Specificity of Mediastinoscopy

100% - (Dietlein)

Mortality

CT and PET mortality

0% - (Dietlein)

Surgery mortality

3.7% - (Dietlein)

Mediastinoscopy mortality

0.5% - (Dietlein)

Life Expectancy

Life expectancy after surgery

N0/1; M0: 4.5 years

N2/3; M0: 1.8 years

M1:       0.5 years

___________________(Dietlein)___________________

Life expectancy after palliation

N0/1; M0: 2.6 years

N2/3; M0: 1.8 years

M1:       0.5 years

___________________(Dietlein)___________________

Other Assumptions

Percentage of patients straight to
_______________
surgery_______________

58% (Dietlein)

Complication rate of surgery

37.5% (Own estimate based on Viney)

Probability patients upstage during
thoractomy from N0/1 to N2/3

10% (HTBS)

14



More intriguing information

1. The name is absent
2. MICROWORLDS BASED ON LINEAR EQUATION SYSTEMS: A NEW APPROACH TO COMPLEX PROBLEM SOLVING AND EXPERIMENTAL RESULTS
3. The name is absent
4. The name is absent
5. The name is absent
6. The name is absent
7. The name is absent
8. The name is absent
9. Testing Hypotheses in an I(2) Model with Applications to the Persistent Long Swings in the Dmk/$ Rate
10. Cross border cooperation –promoter of tourism development
11. Optimal Tax Policy when Firms are Internationally Mobile
12. Equity Markets and Economic Development: What Do We Know
13. The role of statin drugs in combating cardiovascular diseases
14. An Interview with Thomas J. Sargent
15. Migrant Business Networks and FDI
16. New Evidence on the Puzzles. Results from Agnostic Identification on Monetary Policy and Exchange Rates.
17. The name is absent
18. The name is absent
19. LOCAL CONTROL AND IMPROVEMENT OF COMMUNITY SERVICE
20. Citizenship